Latest News

Latest News

News from the World Hepatitis Alliance

World Day of Social Justice: fighting for our right to health

20 Feb 2017 Tara Farrell

By Raquel Peck By the time you finish reading this blog, a man, woman or child will have died from viral hepatitis; a disease which can either be...

New World Hepatitis Alliance President announced

26 Jan 2017 Bridie Taylor

Michael Ninburg appointed as WHA President Today, the World Hepatitis Alliance (WHA) Executive Board announced that, following a comprehensive...

Elimination to take centre stage at APASL 2017

24 Jan 2017 Bridie Taylor

The elimination of viral hepatitis to dominate discussions at the 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL...

Industry and civil Society unite to help deliver hepatitis C medication in low-and middle-income countries

18 Jan 2017 Tara Farrell

Today, MasterCard signed a Memorandum of Understanding (MoU) with Gilead Sciences, Inc. to explore, in a pilot programme, the potential of using the...

India’s young filmmakers give a global voice to viral hepatitis survivors

14 Dec 2016 Tara Farrell

Today, media charity tve today launches four powerful films that give voice to five individuals in India who have survived viral hepatitis, one of...

Leave no-one behind

2 Dec 2016 Tara Farrell

On 3rd December, patients across the globe will unite to mark Patient Solidarity Day and reaffirm that patient-centred universal health coverage is...

HIV coinfection more than triples the risk of liver disease, liver failure and liver-related death from viral hepatitis

1 Dec 2016 Bridie Taylor

On World AIDS Day, the World Hepatitis Alliance calls for increased recognition of viral hepatitis and HIV coinfections London, 1 December 2016 –...

New WHA Executive Board announced

28 Nov 2016 Bridie Taylor

Our voting members have spoken and the votes have been counted! Following a fiercely contested election, we are delighted to announce our new...

WHO launches first-ever global report on access to hepatitis C treatment

27 Oct 2016 Tara Farrell

New report from the World Health Organization (WHO) released today shows how political will, civil society advocacy and pricing negotiations are...

Launch of World Hepatitis Day 2016 Report

19 Oct 2016 Tara Farrell

On 28 July 2016, patients, governments, organisations and many others participated the most successful World Hepatitis Day (WHD) to date, with 174...

New database sheds light on generic hep C drugs in low-and middle-income countries and how to access them

13 Oct 2016 Bridie Taylor

To provide information on the intellectual property status of priority medicines in 101 low-and middle-income countries, the Medicines Patent Pool (...

Interested in leading a global organisation in the fight to eliminate viral hepatitis?

15 Sep 2016 Bridie Taylor

The World Hepatitis Alliance (WHA) is seeking nominations for two key offices; President-Elect and Regional Executive Board Members, to drive action...

Europe Adopts Regional Action Plan to Eliminate Viral Hepatitis

14 Sep 2016 Tara Farrell

Today, representatives from the 53 countries in the WHO European Region adopted the first-ever Action Plan for viral hepatitis. The Action Plan,...

CHANGE OF DATE: WORLD HEPATITIS SUMMIT 2017

12 Sep 2016 Tara Farrell

Due to unforeseen circumstances, the Committee of the World Hepatitis Summit - comprising the World Hepatitis Alliance; World Health Organization and...

100 ACTIVISTS STAGE A “DIE-IN” TO SEND A POWERFUL MESSAGE TO WORLD LEADERS TO ELIMINATE VIRAL HEPATITIS

28 Jul 2016 Tara Farrell

On World Hepatitis Day, the World Hepatitis Alliance and The Hepatitis C Trust, held the first hepatitis “die-in” at Piccadilly Circus in London to...

Globally, 95% of people living with a cancer-causing illness are unaware

28 Jul 2016 Bridie Taylor

On World Hepatitis Day, the World Hepatitis Alliance is calling for a dramatic scale up in viral hepatitis testing to reduce liver cancer deaths...

Treatment of hepatitis C has more than doubled since 2013. Yet 99% of people are still being denied the life-saving cure

28 Jul 2016 Bridie Taylor

On World Hepatitis Day, the World Hepatitis Alliance is calling for a dramatic scale up in testing and treatment across all countries to reduce the...

Viral hepatitis is the 7th leading killer worldwide, killing more people than HIV, TB or malaria

7 Jul 2016 Tara Farrell

Viral hepatitis has become the seventh leading cause of death and disability in the world, killing more people in a year than HIV/AIDs, tuberculosis...

WHA presents Knowledge for Change webinar series to enhance hepatitis knowledge

8 Jun 2016 Bridie Taylor

Advocacy is a powerful tool but in order to effectively advocate and bring about change, it is important to first build our knowledge in key areas...

Governments on track to eliminate viral hepatitis by 2030

28 May 2016 Tara Farrell

194 Member States commit to eliminating viral hepatitis at World Health Assembly On 28 May, 194 Member States made a historic commitment to eliminate...

Pages

News from infohep

Is better treatment reducing liver cancer among people with hepatitis B?

23 Feb 2017 Liz Highleyman
The incidence of hepatocellular carcinoma (HCC) appears to be decreasing and mortality improving among chronic hepatitis B patients treated with...

New hepatitis C infections among HIV-positive gay men drop by half after direct-acting antiviral roll-out in Netherlands

17 Feb 2017 Liz Highleyman
A little more than a year after the Netherlands instituted a policy allowing unrestricted access to direct-acting antivirals for the treatment of...

High hepatitis C prevalence seen in Amsterdam PrEP study participants

6 Feb 2017 Gus Cairns
Researchers from the Dutch pre-exposure prophylaxis (PrEP) demonstration study, AmPrEP, have found an unexpectedly high rate of hepatitis C virus (...

Curing hepatitis C reduces the risk of diabetes & kidney failure in people with HIV/HCV co-infection

1 Feb 2017 Keith Alcorn
Curing hepatitis C infection substantially reduces the risk of developing type 2 diabetes in people with HIV/hepatitis C virus (HCV) co-infection,...

Lonafarnib lowers hepatitis delta levels with acceptable side-effects

27 Jan 2017 Liz Highleyman
The hepatitis delta virus (HDV) assembly inhibitor lonafarnib reduces HDV viral load and can be safely boosted with ritonavir to allow for higher and...

Is DAA treatment for hepatitis C reducing the need for liver transplants?

25 Jan 2017 Liz Highleyman
People successfully treated for hepatitis are less likely to need liver transplants and less likely to die while on a transplant waiting list,...

Curing hepatitis C reduces liver-related complications and death

23 Jan 2017 Liz Highleyman
People with hepatitis C who achieve sustained virological response to treatment had lower liver-related morbidity and mortality rates compared to...

Liver cirrhosis and decompensation still on the rise among people with hepatitis C

18 Jan 2017 Liz Highleyman
Complications of advanced liver disease including cirrhosis and hepatic decompensation have risen over the past decade among people with chronic...

Tenofovir alafenamide approved for hepatitis B in Europe

16 Jan 2017 Liz Highleyman
The European Commission this week granted marketing authorisation for tenofovir alafenamide, to be sold under the brand name Vemlidy, for the...

Nivolumab demonstrates good safety and promising response rates in liver cancer study

3 Jan 2017 Liz Highleyman
Nivolumab (Opdivo), an antibody that blocks the PD-1 receptor and restores T-cell anti-tumour activity, appeared safe and was associated with...